Epidemiology of Clostridioides difficile Infections in Germany, 2010–2019: A Review from Four Public Databases

被引：0
|
作者：
Gordon Brestrich
Frederick J. Angulo
Fabian K. Berger
Christian Brösamle
Stefan Hagel
Andreas Leischker
Christoph Lübbert
Friederike Maechler
Sophie-Susann Merbecks
Nadia Minarovic
Jennifer C. Moïsi
Lutz von Müller
Phillip A. Reuken
Thomas Weinke
Holly Yu
Alexander Mellmann
机构：
[1] Pfizer Pharma GmbH,Institute of Medical Microbiology and Hygiene
[2] Medical Development and Scientific/Clinical Affairs,Institute for Infectious Diseases and Infection Control
[3] Pfizer Vaccines,Department of Infectious Diseases/Tropical Medicine, Nephrology and Rheumatology
[4] University of Saarland,Division of Infectious Diseases and Tropical Medicine, Department of Medicine II
[5] National Reference Center for Clostridioides (Clostridium) Difficile,Interdisciplinary Center for Infectious Diseases (ZINF)
[6] University Hospital–Friedrich Schiller University,Institute of Hygiene and Environmental Medicine
[7] Phillips University,Department of Internal Medicine IV
[8] Hospital St. Georg,Department for Gastroenterology and Infection
[9] University Medical Center,Institute of Hygiene
[10] University Hospital,Institute of Laboratory Medicine, Microbiology and Hygiene (LMH)
[11] National Reference Center for Surveillance of Nosocomial Infections,undefined
[12] Charité-Universitätsmedizin,undefined
[13] Hygiene and Environmental Medicine,undefined
[14] University Hospital,undefined
[15] Friedrich-Schiller-University,undefined
[16] Ernst Von Bergmann Clinic,undefined
[17] Health Economics and Outcomes Research,undefined
[18] Pfizer Vaccines,undefined
[19] University Hospital,undefined
[20] Medical Development and Scientific/Clinical Affairs,undefined
[21] Pfizer Vaccines,undefined
[22] AMS Advanced Medical Services GmbH,undefined
[23] Christophorus-Kliniken GmbH,undefined
来源：
Infectious Diseases and Therapy | 2023年 / 12卷
关键词：
Burden of disease; Germany; Hospital; Incidence; Surveillance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1057 / 1072
页数：15
相关论文
共 50 条
  • [41] Molecular epidemiology and genotype-specific disease severity of hepatitis E virus infections in Germany, 2010-2019
    Schemmerer, Mathias
    Wenzel, Juergen J.
    Stark, Klaus
    Faber, Mirko
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 1754 - 1763
  • [42] Molecular epidemiology of Clostridioides difficile obtained from fecal samples of wild animals in Brazil
    Lima, Maiara C.
    Basso, Roberta M.
    Cerri, Fabricio M.
    Rahal, Sheila C.
    Lima, Heloisa C.
    Zanon, Isabela P.
    Carvalho, Gabriela M.
    Silva, Rodrigo Otavio S.
    Arroyo, Luis G.
    Oliveira-Filho, Jose P.
    Borges, Alexandre S.
    PESQUISA VETERINARIA BRASILEIRA, 2024, 44
  • [43] The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent Clostridioides difficile infections in Germany
    Peri, Rosemarie
    Aguilar, Rebeca Cruz
    Tueffers, Kester
    Erhardt, Andreas
    Link, Alexander
    Ehlermann, Philipp
    Angeli, Wolfgang
    Frank, Thorsten
    Storr, Martin
    Gluck, Thomas
    Sturm, Andreas
    Rosien, Ulrich
    Tacke, Frank
    Bachmann, Oliver
    Solbach, Philipp
    Stallmach, Andreas
    Goeser, Felix
    Vehreschild, Maria J. G. T.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (05) : 716 - 722
  • [44] The burden of Clostridioides difficile infections in South-East Asia and the Western Pacific: A narrative review
    Angulo, Frederick J.
    Ghia, Canna
    Fletcher, Mark A.
    Ozbilgili, Egemen
    Morales, Graciela del Carmen
    ANAEROBE, 2024, 86
  • [45] A systematic review of real-world healthcare resource use and costs of Clostridioides difficile infections
    Malone, Daniel C.
    Armstrong, Edward P.
    Gratie, Dan
    Pham, Sissi V.
    Amin, Alpesh
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2023, 3 (01):
  • [46] TWELVE-MONTH INPATIENT MORTALITY AND ECONOMIC BURDEN OF CLOSTRIDIOIDES DIFFICILE INFECTIONS IN THE US: 2016-2019
    Tillotson, G.
    Le, J.
    Lodise, T. P.
    Bochan, M.
    Ng, S.
    Poole, C.
    Guo, A.
    Feuerstadt, P.
    VALUE IN HEALTH, 2022, 25 (07) : S431 - S432
  • [47] Clostridioides difficile infections were predominantly driven by fluoroquinolone-resistant Clostridioides difficile ribotypes 176 and 001 in Slovakia in 2018-2019 (vol 62, pg 106824, 2023)
    Plankaova, Adriana
    Brajerova, Marie
    Capek, Vaclav
    Novotna, Gabriela Balikova
    Kinross, Pete
    Skalova, Jana
    Soltesova, Anna
    Drevinek, Pavel
    Krutova, Marcela
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2025, 65 (01)
  • [48] Molecular Epidemiology, Clinical Course, and Implementation of Specific Hygiene Measures in Hospitalised Patients with Clostridioides difficile Infection in Brandenburg, Germany
    Dirks, Esther E. E.
    Lukovic, Jasminka A. A.
    Peltroche-Llacsahuanga, Heidrun
    Herrmann, Anke
    Mellmann, Alexander
    Arvand, Mardjan
    MICROORGANISMS, 2023, 11 (01)
  • [49] Hospital resource endowments and nosocomial infections: longitudinal evidence from the English National Health Service on Clostridioides difficile between 2011 and 2019
    Stead, S.
    Vogt, L.
    Antons, D.
    Salge, T. O.
    Gecht, J.
    Klasen, M.
    Sopka, S.
    JOURNAL OF HOSPITAL INFECTION, 2023, 134 : 129 - 137
  • [50] Clostridioides difficile infections complicating combat-injured patients from Iraq and Afghanistan
    Schall, Sarah E.
    Li, Ping
    Whitman, Timothy J.
    Petfield, Joseph L.
    Tribble, David R.
    Blyth, Dana M.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (09): : 1100 - 1102
12345